Glen de Vries

GLEN DE VRIES is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Syst�mes. Glen has been driving Medidata's mission since the company's inception in 1999, "powering smarter treatments and healthier people" by advancing...See more

GLEN DE VRIES is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Syst�mes. Glen has been driving Medidata's mission since the company's inception in 1999, "powering smarter treatments and healthier people" by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen's work has appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics , and other journals. He also serves as a trustee of Carnegie Mellon University. JEREMY BLACHMAN is a writer who works with leaders across industries on getting their ideas out to the world. He has published two novels and developed television pilots for NBC. His writing has appeared in The New York Times , The Wall Street Journal , and many other prominent publications. See less